Tjalf Ziemssen

Center for Neurosciences — United States

Medicine · Health Sciences

64h-index17.5kcitations707works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(377), Peripheral Neuropathies and Disorders(65), Immunotherapy and Immune Responses(60), Polyomavirus and related diseases(57), Sphingolipid Metabolism and Signaling(42)

Publications705 total

Elevated neurofilament light levels in acute anorexia nervosa are associated with alterations in white matter volume and connectivity networks
Journal of Child Psychology and Psychiatry·2025Open Access
Education Research: Can Large Language Models Match MS Specialist Training?
Neurology Education·2025· 3 citedOpen Access
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis
Multiple Sclerosis Journal·2025· 2 citedOpen Access
Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis
2025Open Access
Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosis
Journal of Neurology·2025Open Access
Der 2-Minuten-Gehtest bei Personen mit Multipler Sklerose: Eine Untersuchung zu Kreislaufbelastung und Belastungswahrnehmung im klinischen Kontext
physioscience·2025
A Review of the Impact of Platform Therapies (DMTs) on Associated Clinical Symptoms of Multiple Sclerosis
Journal of Multidisciplinary Healthcare·2025Open Access
Phenotyping and characterising gait profiles of people with multiple sclerosis
Scientific Reports·2025Open Access
Variations in neuronal integrity affect directed communication in distributed networks during inhibitory control
International Journal of Psychophysiology·2025
Experiences of People with Multiple Sclerosis in Sensor-Based Jump Assessment
Bioengineering·2025· 2 citedOpen Access
Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort study
Multiple Sclerosis Journal·2025· 4 cited
Diagnostic uncertainty in the era of biosimilar natalizumab—The case for harmonizing anti-JCV antibody testing
Multiple Sclerosis Journal·2025· 2 cited
CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany
Frontiers in Neurology·2025· 2 citedOpen Access
A roadmap for safe, regulation-compliant Living Labs for AI and digital health development
Science Advances·2025· 8 citedOpen Access
Der 2-Minuten-Gehtest bei Personen mit Multipler Sklerose: Eine Untersuchung zu Kreislaufbelastung und Belastungswahrnehmung
physioscience·2025
Wird die Multiple Sklerose-Therapie in Zukunft digital?
DGNeurologie·2025Open Access
NeofiLos –sNfL in Daily Clinical Routine (P5-1.015)
Neurology·2025· 1 cited
Hidden Problems in Multiple Sclerosis: Gaps Between Patient Experience and Outcome Assessments (P7-1.003)
Neurology·2025
Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course (P11-1.003)
Neurology·2025
Variations in neuronal cytoskeletal integrity affect directed communication in distributed networks during inhibitory control
Communications Biology·2025· 2 citedOpen Access
page 1 of 36Next →

Frequent Co-authors

Katja Akgün(7), Rocco Haase(6), Helmut Butzkueven(5), Xavier Montalbán(5), Eva Havrdová(4), François Grand’Maison(4), Hernán Inojosa(4), Alexandre Prat(3), Pierre Duquette(3), María Trojano(3), Vincent Van Pesch(3), Mark S. Freedman(3), Douglas Jeffery(3), Sven G. Meuth(3), Undine Proschmann(3), Krzysztof Selmaj(3), Nicola De Stefano(3), Simone Kern(3), Massimo Filippi(3), Alexey Boyко(3)